CIK 0001730463 · Non-accelerated filer<br>Smaller reporting company
Autolus Therapeutics plc
Sign in to watch- Ticker
- AUTL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 20 3829 6230
- Business address
- THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
- Former names
- Autolus Therapeutics Ltd
- SC 13D/A Stake Beneficial Ownership Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 8-K Event Other events
- 144 Insider Sale of Securities
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- NT 10-Q Other NT 10-Q
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change · Regulation FD disclosure
- S-3ASR Offering Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
Page 7 of 17 · 340 filings